Back to search
FDAFDA · Food and drugs·Recall number D-0337-2018

Linezolid Injection 600 mg/300 mL (2 mg/mL), 300 mL Single-use, ready-to-use flexible plastic infusion bags in a foil laminate overwrap, Rx only, Mfd in India for: AuroMedics Pharma LLC, Dayton, NJ --- NDC 55150-242-51

Published February 14, 2018 · Recall initiated: December 20, 2017

Summary

FDA records drug Class I recall D-0337-2018, published February 14, 2018 and initiated December 20, 2017. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: 9,050 bags; Lot: Lot # CLZ160007, Exp August 2018. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; white particulate matter identified as mold was found in one bag

What to do

Voluntary: Firm initiated · Letter

Get an email if LINEZOLID has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LINEZOLID
Manufacturer
AuroMedics Pharma LLC
Distributor
Product was distributed throughout United States.
Lot
Lot # CLZ160007, Exp August 2018
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Linezolid Injection 600 mg/300 mL (2 mg/mL), 300 mL Single-use, ready-to-use flexible plastic infusion bags in a foil laminate overwrap, Rx only, Mfd in India for: AuroMedics Pharma LLC, Dayton, NJ --- NDC 55150-242-51 recalled?

Yes. FDA published recall D-0337-2018 on February 14, 2018. Reported hazard: Presence of Particulate Matter; white particulate matter identified as mold was found in one bag

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LINEZOLID.